Javascript must be enabled to continue!
Study on the correlation between PPARγ, Aβ1-42, miR-155 and the occurrence and development of diabetes
View through CrossRef
The objective of this research was to study the correlation between PPARγ, Aβ1-42, miR-155 and the occurrence and development of diabetes. For this purpose, 52 patients with diabetes who were hospitalized from September 2019 to May 2021 were selected as the research objects. They were grouped according to the severity of the disease, which was pre-diabetes (n=16), mild (n=25), and moderate (n=16). =11), another 20 healthy subjects were taken as the control group, and the levels of PPARγ, Aβ1-42, miR-155 in each group were measured, and the correlation between changes in the levels of various indicators and the occurrence and development of diabetes was explored. Results showed that comparison of age, gender, course of disease, BMI, living habits, comorbidities, and high-density lipoprotein among the groups of diabetic patients (P>0.05); the levels of total cholesterol, triglycerides and low-density cholesterol decreased with the development of diabetes (P<0.05) ); Compared with the healthy group, the levels of PPARγ and miR-155 were significantly reduced, and the levels of Aβ1-42 were significantly increased (P<0.05); compared with the prediabetes, the levels of mild and moderate PPARγ and miR-155 showed a downward trend, and Aβ1 -42 level showed an upward trend (P<0.05); PPARγ and miR-155 levels were negatively correlated with pre-diabetes, mild, and moderate; Aβ1-42 was positively correlated with pre-diabetes, mild, and moderate (P<0.05) ; PPARγ, Aβ1-42, miR-155 levels can effectively predict the occurrence and development of diabetes, and the sensitivity, specificity and accuracy of the detection of diabetes by various indicators, positive predictive value and negative predictive value are significantly higher. It is concluded that PPARγ, Aβ1-42, miR-155 are closely related to the occurrence and development of diabetes, and there are many influencing factors of diabetes. Clinical intervention measures can be taken according to specific conditions.
Title: Study on the correlation between PPARγ, Aβ1-42, miR-155 and the occurrence and development of diabetes
Description:
The objective of this research was to study the correlation between PPARγ, Aβ1-42, miR-155 and the occurrence and development of diabetes.
For this purpose, 52 patients with diabetes who were hospitalized from September 2019 to May 2021 were selected as the research objects.
They were grouped according to the severity of the disease, which was pre-diabetes (n=16), mild (n=25), and moderate (n=16).
=11), another 20 healthy subjects were taken as the control group, and the levels of PPARγ, Aβ1-42, miR-155 in each group were measured, and the correlation between changes in the levels of various indicators and the occurrence and development of diabetes was explored.
Results showed that comparison of age, gender, course of disease, BMI, living habits, comorbidities, and high-density lipoprotein among the groups of diabetic patients (P>0.
05); the levels of total cholesterol, triglycerides and low-density cholesterol decreased with the development of diabetes (P<0.
05) ); Compared with the healthy group, the levels of PPARγ and miR-155 were significantly reduced, and the levels of Aβ1-42 were significantly increased (P<0.
05); compared with the prediabetes, the levels of mild and moderate PPARγ and miR-155 showed a downward trend, and Aβ1 -42 level showed an upward trend (P<0.
05); PPARγ and miR-155 levels were negatively correlated with pre-diabetes, mild, and moderate; Aβ1-42 was positively correlated with pre-diabetes, mild, and moderate (P<0.
05) ; PPARγ, Aβ1-42, miR-155 levels can effectively predict the occurrence and development of diabetes, and the sensitivity, specificity and accuracy of the detection of diabetes by various indicators, positive predictive value and negative predictive value are significantly higher.
It is concluded that PPARγ, Aβ1-42, miR-155 are closely related to the occurrence and development of diabetes, and there are many influencing factors of diabetes.
Clinical intervention measures can be taken according to specific conditions.
Related Results
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
Objectives
The activation of coagulation and fibrinolysis plays a critical role in the incidence of coronary events. MicroRNAs (miRNAs) are small non-coding ribon...
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
AbstractMicroRNAs are a class of non‐coding molecules found to regulate a variety of cellular functions in health and disease. Dysregulation of microRNAs is involved in liver disea...
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
Introduction: Acute myocardial infarction (AMI) is a severe coronary heart disease. Targeted miRNAs studies implicated two main pathways in the regulation of AMI namely pro-apopt...
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
Abstract
Background
MicroRNAs (miRNAs) can function as either oncogenes or tumor suppressor genes via regulation of cell proliferation and/or apo...
A Systematic Evidence‐Based Review Regarding miRNA Polymorphisms in Recurrent Implantation Failure
A Systematic Evidence‐Based Review Regarding miRNA Polymorphisms in Recurrent Implantation Failure
ABSTRACT
Background
This systematic review aimed to evaluate whether specific single nucleotide polymorphisms (SNPs) in m...
MICRORNAS IN HYPERTENSION: MOLECULAR MECHANISMS AND THERAPEUTIC PERSPECTIVES - A BIOINFORMATICS APPROACH
MICRORNAS IN HYPERTENSION: MOLECULAR MECHANISMS AND THERAPEUTIC PERSPECTIVES - A BIOINFORMATICS APPROACH
This study presents a comprehensive structural bioinformatics analysis of five key microRNAs (miR-21, miR-126, miR-133a, miR-155, and miR-181a), focusing on their secondary and ter...
Troglitazone increased human coronary artery smooth muscle cells proliferation but inhibited the apoptosis through the PPARγ
Troglitazone increased human coronary artery smooth muscle cells proliferation but inhibited the apoptosis through the PPARγ
Background
TZDs (thiazolidinediones) are a class of antidiabetic drugs extensively used in the treatment of diabetes mellitus type 2. As ligands of PPARγ (peroxis...
Abstract 1806: AP-1 transcriptionally regulates expression of miR-155 in colon cancer cells.
Abstract 1806: AP-1 transcriptionally regulates expression of miR-155 in colon cancer cells.
Abstract
Accumulating evidence indicates elevated S100P promotes the pathogenesis of cancers, including colon cancer. S100P exerts its effects by binding to and acti...

